Yolanda Cervantes
Biographic Data
| ID | 7506803 |
|---|---|
| NAME | Yolanda Cervantes |
| GIVEN NAMES | Yolanda |
| FAMILY NAME | Cervantes |
| SIGNATURE | CERVANTES Y |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2002 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 0 |
Economic impact of a rotavirus vaccination program in Mexico
A national rotavirus vaccination program in Mexico is projected to reduce childhood incidence and mortality and to be highly cost-effective based on the World Health Organization's thresholds for cost-effective interventions
Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine
Our study confirms that the DTPw-HB/Hib pentavalent vaccine is highly immunogenic as a primary vaccination in children who received an HB vaccine at birth, with the pentavalent combination inducing both persisting immunity and boostable memory. The pentavalent vaccine was safe both for primary and booster vaccinations. Thus, this study in Costa Rican infants supports the routine use of the pentavalent DTPw-HB/Hib vaccine as part of childhood vacc…
No prominent works on this page.
Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine
Our study confirms that the DTPw-HB/Hib pentavalent vaccine is highly immunogenic as a primary vaccination in children who received an HB vaccine at birth, with the pentavalent combination inducing both persisting immunity and boostable memory. The pentavalent vaccine was safe both for primary and booster vaccinations. Thus, this study in Costa Rican infants supports the routine use of the pentavalent DTPw-HB/Hib vaccine as part of childhood vacc…
Economic impact of a rotavirus vaccination program in Mexico
A national rotavirus vaccination program in Mexico is projected to reduce childhood incidence and mortality and to be highly cost-effective based on the World Health Organization's thresholds for cost-effective interventions
Medicine (2 works) · Pediatrics (2 works) · Vaccination (2 works) · Virology (2 works) · Antibody (1 works) · Bacterial Infections and Vaccines (1 works) · Booster dose (1 works) · Cohort (1 works) · Conjugate vaccine (1 works) · Cost effectiveness (1 works)